Pharmafile Logo
Pharmafocus logo
Advanced Search
Blog footer

Digital Pharma: Lilly aims to be social on its Lillypad

September 16, 2010
Medical Communications Digital Pharma blog, Twitter, blog, lilly

Lilly has jumped feet first into the social media scene this week, launching a corporate blog and a Twitter account. …

News

AstraZeneca’s Brilinta delayed

September 16, 2010
Sales and Marketing Brillinta, Effient, Plavix, clopidogrel

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …

News

Representing medium-sized pharma

September 16, 2010
Sales and Marketing European Medicines Group, UCB

UCB’s Matthew Speers is the new chairman of the European Medicines Group, which represents European-owned pharma companies in the UK. …

Feature

GSK’s leukaemia drug rejected by NICE

September 16, 2010
Sales and Marketing Arzerra, GSK, NHS, NICE

GSK’s leukaemia treatment Arzerra has been rejected by NICE, which says the drug does not represent good value for the …

News

Gilenya approved in Russia, awaits FDA decision

September 16, 2010
Sales and Marketing Cladribine, Gilena, MS

Novartis has won approval for its MS drug Gilenya in Russia but still awaits the FDA’s decision on its fate …

News

Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

News

FDA warns BMS over manufacturing plant in Puerto Rico

September 15, 2010
Manufacturing and Production BMS, FDA, GMP, Puerto Rico

A plant operated by Bristol-Myers Squibb in Puerto Rico has been cited by the US Food and Drug Administration for …

News

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010
Sales and Marketing Kinapse, White paper

Feature
White paper

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature
Boehringer Ingelheim Facebook picture

Digital Pharma: Boehringer gets social with Facebook

September 14, 2010
Medical Communications Boehringer, Digital Pharma blog, Facebook

Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …

News

Positive results for irritable bowel syndrome drug

September 14, 2010
Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …

News

iPhone app is download hit for Doctors.net.uk

September 14, 2010
Medical Communications Doctors.net.uk, doctors, iphone, tala, tim ringrose

An app launched by Doctors.net.uk in response to a surge in the number of doctors signing up for iPhones, has …

News
Press release

Future of Roche diabetes trial uncertain

September 14, 2010
Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …

News

Growth slowdown predicted for pharma packaging

September 14, 2010
Manufacturing and Production packaging, pharma packaging

New regulatory requirements in the US are driving growth in the country’s pharmaceutical packaging market, according to market research firm …

News

Novasep appoints new supervisory board chairman

September 14, 2010
Manufacturing and Production Novasep, appointment, manufacturing and production

French contract manufacturing firm Novasep has appointed Bernard Dubois to its top management team. Most recently a consultant, Bernard formerly …

Appointment

Genzyme planning 1,000 job cuts

September 14, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026